Cetera Advisors’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,685
Closed -$10.9K 1661
2022
Q4
$10.9K Sell
11,685
-790
-6% -$1.05K ﹤0.01% 1586
2022
Q3
$21K Buy
12,475
+750
+6% +$1.96K ﹤0.01% 1248
2022
Q2
$25K Sell
11,725
-17,000
-59% -$45.2K ﹤0.01% 1338
2022
Q1
$102K Buy
28,725
+1,500
+6% +$4.35K ﹤0.01% 1357
2021
Q4
$101K Buy
27,225
+1,470
+6% +$9.02K ﹤0.01% 1379
2021
Q3
$190K Buy
25,755
+1,158
+5% +$9.91K ﹤0.01% 1311
2021
Q2
$328K Buy
24,597
+12,249
+99% +$120K 0.01% 1009
2021
Q1
$93K Buy
+12,348
New +$139K ﹤0.01% 1187

Other funds holding CLOV

Cetera Advisors's CLOV Position: Q1 2023 in Review

Cetera Advisors sold out of Clover Health Investments (CLOV) in Q1 2023, closing a stake of 11,685 shares — an estimated $10.9K sold.

Cetera Advisors first reported a position in CLOV in Q1 2021 and held it in 8 quarters. The position peaked at $328K in Q2 2021. 157 funds tracked by Wall St. Rank hold CLOV as of Q1 2023.

  • Cetera Advisors reported no remaining Clover Health Investments position as of Q1 2023 after selling out during the quarter.
  • Cetera Advisors sold 11,685 Clover Health Investments shares in Q1 2023, an estimated $10.9K.
  • Cetera Advisors first reported a position in Clover Health Investments in Q1 2021 and held it in 8 quarters.
  • Cetera Advisors's Clover Health Investments position peaked at $328K in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2023.

Based on Cetera Advisors's 13F filing for Q1 2023, filed 15 May 2023.